Cancer News
Paclitaxel Plus RT Controls Advanced Endometrial Cancer

CAR T Cells: A Look Under the Hood and Down the Road

ASTRO Issues More 'Don't' Recommendations

Male Pattern Baldness Linked to Aggressive Prostate Cancer

340B Drug Pricing Program Needs Updating, Says ASCO
Specific baldness pattern linked with increased prostate cancer risk

American Association for Cancer Research releases 2014 cancer progress report: research is transforming lives

Cancer Council publishes first Australian guidelines on Barrett's Oesophagus and oesophageal adenocarcinoma

Research sheds light on cognitive losses seen with chemotherapy, autoimmune diseases

Study indicates that learning and memory defects are reversible in zebrafish model of neurofibromatosis, a human genetic disease
New Gene Variants for Prostate Cancer Identified

Golden Retriever Study Sniffs for Cancer Clues

Can Prediabetes Raise Risk of Certain Cancers?

New Survey Reveals that Prostate Cancer Impacts Sex Lives More than Any Other Aspect of Patients' Lives

Kidney and Thyroid Cancer Rates Up Among U.S. Children, Study Finds
Special Recognition for Jonsson Comprehensive Cancer Center at Avon Walk for Breast Cancer

FDA Approves Game-Changing Melanoma Drug that Turns on Immune System to Fight Deadly Cancers

Vault Nanoparticles Engineered at UCLA Show Promise for Cancer Treatment

JCCC Scientist Honored with Prestigious Biomedical Science Award

PROFILE: Dr. Denis Evseenko—Harnessing the Regenerative Power of Stem Cells in Cancer Research
Systemic therapy in men with metastatic castration-resistant prostate cancer: American society of clinical oncology and cancer care Ontario clinical practice guideline

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): An open-label, multicentre, phase 2, randomised controlled trial

Menstrual pain and epithelial ovarian cancer risk

Safety and effectiveness of bevacizumab-containing treatment for non–small-cell lung cancer: Final results of the ARIES observational cohort study

Randomized, placebo-controlled trial of K1 acupoint acustimulation to prevent cisplatin-induced or oxaliplatin-induced nausea